However, low-dose FAK inhibition was reported to increase tumor growth and angiogenesis, which was contrary to higher FAK inhibition, indicating that FAK can have a nonlinear dose-dependent function in regulating tumor growth and angiogenesis [19]. The gene discussed is PTK2; the disease is neoplasm.